188 related articles for article (PubMed ID: 37470692)
21. Degradation of Mcl-1 through GSK-3β Activation Regulates Apoptosis Induced by Bufalin in Non-Small Cell Lung Cancer H1975 Cells.
Kang XH; Zhang JH; Zhang QQ; Cui YH; Wang Y; Kou WZ; Miao ZH; Lu P; Wang LF; Xu ZY; Cao F
Cell Physiol Biochem; 2017; 41(5):2067-2076. PubMed ID: 28419994
[TBL] [Abstract][Full Text] [Related]
22. Celastrol induces ROS-mediated apoptosis via directly targeting peroxiredoxin-2 in gastric cancer cells.
Chen X; Zhao Y; Luo W; Chen S; Lin F; Zhang X; Fan S; Shen X; Wang Y; Liang G
Theranostics; 2020; 10(22):10290-10308. PubMed ID: 32929349
[No Abstract] [Full Text] [Related]
23. Cip2a induces arginine biosynthesis and promotes tumor progression in non-small cell lung cancer.
Chen D; Fan S; Wang J; Liang Y; Li P; Lv X; Sun Y; Wang Q; Liu H; Zhang C; Yi Y
Mol Carcinog; 2023 Apr; 62(4):561-572. PubMed ID: 36705466
[TBL] [Abstract][Full Text] [Related]
24. Helicobacter pylori enhances CIP2A expression and cell proliferation via JNK2/ATF2 signaling in human gastric cancer cells.
Zhao Y; Li Y; Han J; Liu T; Guan Q; Zhao P; Guo L; Liu K; He D
Int J Mol Med; 2014 Mar; 33(3):703-10. PubMed ID: 24398514
[TBL] [Abstract][Full Text] [Related]
25. Afatinib induces apoptosis in NSCLC without EGFR mutation through Elk-1-mediated suppression of CIP2A.
Chao TT; Wang CY; Chen YL; Lai CC; Chang FY; Tsai YT; Chao CH; Shiau CW; Huang YC; Yu CJ; Chen KF
Oncotarget; 2015 Feb; 6(4):2164-79. PubMed ID: 25537503
[TBL] [Abstract][Full Text] [Related]
26. Knockdown of cancerous inhibitor of protein phosphatase 2A may sensitize NSCLC cells to cisplatin.
Wei L; Qu W; Sun J; Wang X; Lv L; Xie L; Song X
Cancer Gene Ther; 2014 May; 21(5):194-9. PubMed ID: 24874844
[TBL] [Abstract][Full Text] [Related]
27. Genistein targets the cancerous inhibitor of PP2A to induce growth inhibition and apoptosis in breast cancer cells.
Zhao Q; Zhao M; Parris AB; Xing Y; Yang X
Int J Oncol; 2016 Sep; 49(3):1203-10. PubMed ID: 27574003
[TBL] [Abstract][Full Text] [Related]
28. Cucurbitacin B induces inhibitory effects via CIP2A/PP2A/Akt pathway in glioblastoma multiforme.
Qin S; Li J; Si Y; He Z; Zhang T; Wang D; Liu X; Guo Y; Zhang L; Li S; Li Q; Liu Y
Mol Carcinog; 2018 Jun; 57(6):687-699. PubMed ID: 29393542
[TBL] [Abstract][Full Text] [Related]
29. MYC-dependent regulation and prognostic role of CIP2A in gastric cancer.
Khanna A; Böckelman C; Hemmes A; Junttila MR; Wiksten JP; Lundin M; Junnila S; Murphy DJ; Evan GI; Haglund C; Westermarck J; Ristimäki A
J Natl Cancer Inst; 2009 Jun; 101(11):793-805. PubMed ID: 19470954
[TBL] [Abstract][Full Text] [Related]
30. CIP2A is overexpressed in gastric cancer and its depletion leads to impaired clonogenicity, senescence, or differentiation of tumor cells.
Li W; Ge Z; Liu C; Liu Z; Björkholm M; Jia J; Xu D
Clin Cancer Res; 2008 Jun; 14(12):3722-8. PubMed ID: 18559589
[TBL] [Abstract][Full Text] [Related]
31. Combination of Hypoglycemia and Metformin Impairs Tumor Metabolic Plasticity and Growth by Modulating the PP2A-GSK3β-MCL-1 Axis.
Elgendy M; Cirò M; Hosseini A; Weiszmann J; Mazzarella L; Ferrari E; Cazzoli R; Curigliano G; DeCensi A; Bonanni B; Budillon A; Pelicci PG; Janssens V; Ogris M; Baccarini M; Lanfrancone L; Weckwerth W; Foiani M; Minucci S
Cancer Cell; 2019 May; 35(5):798-815.e5. PubMed ID: 31031016
[TBL] [Abstract][Full Text] [Related]
32. CIP2A is overexpressed in non-small cell lung cancer and correlates with poor prognosis.
Dong QZ; Wang Y; Dong XJ; Li ZX; Tang ZP; Cui QZ; Wang EH
Ann Surg Oncol; 2011 Mar; 18(3):857-65. PubMed ID: 20842459
[TBL] [Abstract][Full Text] [Related]
33. Overexpression and small molecule-triggered downregulation of CIP2A in lung cancer.
Ma L; Wen ZS; Liu Z; Hu Z; Ma J; Chen XQ; Liu YQ; Pu JX; Xiao WL; Sun HD; Zhou GB
PLoS One; 2011; 6(5):e20159. PubMed ID: 21655278
[TBL] [Abstract][Full Text] [Related]
34. CIP2A interacts with AKT1 to promote the malignant biological behaviors of oral squamous cell carcinoma by upregulating the GSK‑3β/β‑catenin pathway.
Che Y; Zhang H; Li H; Wu X
Exp Ther Med; 2023 Nov; 26(5):514. PubMed ID: 37840566
[TBL] [Abstract][Full Text] [Related]
35. Protein Phosphatase 2a Inhibits Gastric Cancer Cell Glycolysis by Reducing MYC Signaling.
Cai Z; Zhang W; Zhou R; Wang Y; Feng Y
Cell Biochem Biophys; 2023 Mar; 81(1):59-68. PubMed ID: 36324030
[TBL] [Abstract][Full Text] [Related]
36. p90/CIP2A mediates breast cancer cell proliferation and apoptosis.
Liu X; Peng B; Li Y; Lei N; Li W; Zhang JY
Mol Biol Rep; 2014 Nov; 41(11):7471-8. PubMed ID: 25086622
[TBL] [Abstract][Full Text] [Related]
37. TD-19, an erlotinib derivative, induces epidermal growth factor receptor wild-type nonsmall-cell lung cancer apoptosis through CIP2A-mediated pathway.
Chao TT; Wang CY; Lai CC; Chen YL; Tsai YT; Chen PT; Lin HI; Huang YC; Shiau CW; Yu CJ; Chen KF
J Pharmacol Exp Ther; 2014 Nov; 351(2):352-8. PubMed ID: 25187431
[TBL] [Abstract][Full Text] [Related]
38. Ethoxysanguinarine inhibits viability and induces apoptosis of colorectal cancer cells by inhibiting CIP2A.
Jin L; Si Y; Hong X; Liu P; Zhu B; Yu H; Zhao X; Qin S; Xiong M; Liu Y; Luo Z; Guo Y
Int J Oncol; 2018 May; 52(5):1569-1578. PubMed ID: 29568959
[TBL] [Abstract][Full Text] [Related]
39. CIP2A is a target of bortezomib in human triple negative breast cancer cells.
Tseng LM; Liu CY; Chang KC; Chu PY; Shiau CW; Chen KF
Breast Cancer Res; 2012 Apr; 14(2):R68. PubMed ID: 22537901
[TBL] [Abstract][Full Text] [Related]
40. Cancer progression by the okadaic acid class of tumor promoters and endogenous protein inhibitors of PP2A, SET and CIP2A.
Fujiki H; Sueoka E; Watanabe T; Komori A; Suganuma M
J Cancer Res Clin Oncol; 2023 Sep; 149(11):9425-9433. PubMed ID: 37097392
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
